Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Navidea Biopharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Sep 2016 Reuters Investment Profile 12 $20.00

Trading Report for (NAVB). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for NAVB. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

26 Sep 2016 Stock Traders Daily 6 $20.00

NAVB: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

26 Sep 2016 New Constructs, LLC 10 $25.00

Thomson Reuters Stock Report - Navidea Biopharmaceuticals Inc (NAVB-A)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

25 Sep 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for NAVB

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

25 Sep 2016 ValuEngine, Inc. 11 $25.00

NAVIDEA BIOPHARMACEUTICALS INC (NAVB=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Value Graph: NAVIDEA BIOPHARM -- NAVB

23 Sep 2016 Ford Investor Services, Inc. 1 $12.00

Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review

Navidea Biopharmaceuticals, Inc. (NAVB) - Financial and Strategic SWOT Analysis Review Summary Navidea Biopharmaceuticals, In...

19 Sep 2016 GlobalData 83 $300.00

"The Economy Matters" Report for NAVB: the economy's impact on NAVB's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

19 Sep 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

NAVB.A - Event Transcript of Navidea Biopharmaceuticals Inc conference call, Sep. 07, 2016 / 8:30AM ET

Edited Event Transcript of NAVB.A conference call, Sep. 07, 2016 / 8:30AM ET Boston, Sep 23, 2016 (Thomson StreetEvents...

07 Sep 2016 Thomson Reuters StreetEvents 12 $75.00